1 Introduction
==============

Epigenome-wide association study (EWAS) is an effective tool to identify the association between epigenetic variation and common disease/phenotype ([@bty163-B4]; [@bty163-B5]). Compared with genome-wide association study (GWAS), the analysis tools of EWAS have lagged behind. To fill this gap, we developed novel and unique features, and improved upon the previous version EWAS1.0 ([@bty163-B6]).

EWAS1.0 was originally designed only for identifying the association between combinations of methylation levels (beta-value) and diseases. EWAS2.0 (<http://www.ewas.org.cn>) is a fully functional software.

2 Features
==========

EWAS2.0 software can perform: (i) epigenome-wide single marker association study; (ii) epigenome-wide methylation haplotype (meplotype) association study and (iii) epigenome-wide association meta-analysis. The methylation data should be cleaned and normalized.

For each DNA methylation loci, EWAS2.0 can carry out t-test or logistic regression analysis to identify the significant associations with case/control or binomial phenotype, perform linear regression analysis to identify the significant results associated with continuous phenotype, and calculate the Pearson\'s correlation coefficients between beta-value and continuous phenotype.

According to our 'population epigenetic framework' ([@bty163-B7]), EWAS2.0 can analyze the methylation genotypes (menotypes: MM, MU and UU, where M is methylation epi-allele and U is unmethylation epi-allele) data, calculate the epi-allele frequency and identify risk epi-allele (calculate Chi-square, *P*-value, odd ratio and 95% confidential interval). EWAS2.0 can also analyze the association between two epi-alleles (M and U) in the same locus, and label the type of the relationships: synergic (two members of homologous chromosomes tend to be methylated simultaneously) or exclusive (one member of homologous chromosomes is methylated, the other member of homologous chromosomes tends to be unmethylated) ([@bty163-B7]).

For multiple DNA methylation loci that are physically close to each other, there are non-random associations of epi-alleles between these loci, which we call methylation disequilibrium (MD) ([@bty163-B7]). EWAS2.0 can calculate the MD coefficients ([@bty163-B7]), identify the MD blocks using Gabriel *et al*.'s algorithm ([@bty163-B1]; [@bty163-B3]) and estimate the frequency of meplotype (a group of specific epi-alleles on a chromosome) using Excoffier *et al*.'s Maximum Likelihood Estimate method ([@bty163-B2]). For case/control data, EWAS2.0 can scan the whole epigenome and identify the disease-related meplotype (calculate Chi-square, *P*-value, odd ratio and 95% confidential interval). We suggest that users perform meplotype analysis to identify the combinations of some SMP loci related to diseases/phenotypes after performing the single SMP analysis.

Since the results of the similar EWAS studies are often inconsistent, we developed an epigenome-wide meta-analysis module. At first, EWAS2.0 test the heterogeneity between individual studies using Cochran's Q-statistics. Then, the fixed effects model (all studies share a common effect size) and a random effects model (each study has a specific effect size) were used to evaluate the association between marker and disease/phenotype. We suggest that users select fixed effects model for low heterogeneity, and random effects model for high heterogeneity.

EWAS2.0 software is a JAVA application based on JAVA 1.7 and is freely available at: <http://www.ewas.org.cn>. The current status of EWAS2.0 is depicted in [Table 1](#bty163-T1){ref-type="table"}. More functions will be added in the future version (such as EWAS for gene region, KEGG pathway, GO categories, network, interacting with genetic marker, regulation of gene expression, RNA modification, histone modification). Some comparisons between different methods can be found in a supplement (<http://www.bioapp.org/ewas/supplement.html>). We expect it to become a useful tool. Table 1.Overview of novel functions in EWAS2.0CategoryDescription-t.testT-test for case/control or binomial phenotype-linearLinear regression analysis for continuous phenotype-logisticLogistic regression analysis for case/control or binomial phenotype-corThe Pearson\'s correlation coefficients for continuous phenotype-SMP.allele_chisqChisq-square test for epi-allele: 2 (phenotype)\*2 (M vs. U) table-SMP.aaIdentify the type of epi-allele association: synergic or exclusive-meplotypeEpigenome-wide meplotype association analysis-MDCalculate the MD coefficient-blockIdentify the MD blocks and calculate the frequency of meplotype-metaEpigenome-wide association meta-analysis

We are grateful to users from more than 30 countries whose feedback helped improve the functionality and usability of EWAS2.0.
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